Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
MicroStrategy $500 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Bloom Energy $388.7 million follow-on offering
The shares are listed on the NYSE
Oak Street Health $180.3 million secondary offering
We advised the joint book-running managers on the equity offering
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
LSB Industries $187 million secondary offering
The stock is listed on the New York Stock Exchange
Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Arrival $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market